empty
05.02.2025 12:44 AM
Pfizer Stock Rises: Why Now is the Best Time to Trade?

On Tuesday, shares of Pfizer Inc. rose by 1.7% in pre-market trading following the release of its Q4 2024 financial report, which exceeded analysts' expectations.

The American pharmaceutical giant reported a net profit of $410 million, or 7 cents per share. This represents a significant improvement compared to a loss of $3.37 billion, or 60 cents per share, during the same period last year.

The company's revenue increased by 22%, totaling $17.76 billion, compared to $14.57 billion in Q4 2023. This performance surpassed FactSet's consensus estimate of $17.35 billion.

This image is no longer relevant

This growth is primarily due to a one-time non-cash revenue return of $3.5 billion associated with its antiviral drug Paxlovid. Additionally, there has been an increase in sales from the Seagen oncology portfolio, the Vyndaqel family for cardiovascular treatment, and overall growth in Paxlovid sales.

Total sales of Paxlovid reached $727 million, a significant improvement compared to the $3.14 billion loss recorded last year, which stemmed from the transition to a traditional commercial sales model in the U.S.

Furthermore, Pfizer experienced a positive impact from currency fluctuations, which added an extra $62 million to its overall revenue. The company's management has reaffirmed its forecast for 2025, projecting revenue between $61 billion and $64 billion, with adjusted earnings per share ranging from $2.80 to $3.00.

According to FactSet, the average analyst expectations are for revenue of $63.07 billion and earnings of $2.91 per share.

Pfizer's CFO, David Denton, expressed confidence that the company will return to pre-pandemic operational margin levels in the coming years and achieve total cost savings of $4.5 billion by the end of 2025.

This situation presents several opportunities for traders. Pfizer's stock has risen following a strong earnings report, which may indicate a continuation of this upward trend, making the company's shares attractive for short- and medium-term speculative trades.

Furthermore, considering the company's long-term prospects in innovative drug development, Pfizer remains a promising asset for investors seeking stable capital growth.

Access to Pfizer shares and other leading global companies is available through the InstaForex trading platform.

Fast order execution, a wide range of instruments including CFDs on U.S. stocks, and no deposit restrictions enable traders to respond swiftly to market changes.

The availability of leverage up to 1:1000 and low commissions also provides additional opportunities for effective capital management.

Given the high volatility in the pharmaceutical sector and the upcoming release of key data on drug sales, investors should monitor Pfizer's stock closely.

In the upcoming quarters, the company is expected to continue growing its revenue by expanding its portfolio of prescription drugs, which could lead to further increases in its share prices.

Ekaterina Kiseleva,
Analytical expert of InstaForex
© 2007-2025
Select timeframe
5
min
15
min
30
min
1
hour
4
hours
1
day
1
week
Earn on cryptocurrency rate changes with InstaForex
Download MetaTrader 4 and open your first trade
  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    JOIN CONTEST

Recommended Stories

Feast in the Storm: S&P 500 Celebrates Gains as Dollar Drowns and China Weakens

S&P 500 Posts Sixth Straight Day of Gains Oil Falls More Than 1% China Manufacturing Activity Plummets as Trump Tariffs Continue to Squeeze Dollar Set for Worst Month

Thomas Frank 12:09 2025-04-30 UTC+2

US Market News Digest for April 30

US stock indices remain on a positive trajectory, but market pressure has intensified due to a sharp drop in Super Micro shares and the upcoming earnings reports from tech heavyweights

Ekaterina Kiseleva 11:13 2025-04-30 UTC+2

Stock markets regaining optimism. Where to find new entry points

European stocks rose amid hopes of easing trade tensions between the US and China. WTI oil fell by 1.54% to $62.05, while Brent declined by 1.51% to $65.86

12:42 2025-04-29 UTC+2

US Market News Digest for April 29

The S&P 500 and Nasdaq continue to climb, maintaining their upward momentum despite mixed performances across other sectors. Softer rhetoric from the Trump administration and expectations of further tariff relief

Ekaterina Kiseleva 11:59 2025-04-29 UTC+2

Optimism returns to the markets: where to look for new growth points

European stocks rose amid hopes for a reduction in trade tensions between the US and China. WTI oil fell by 1.54% to $62.05, Brent by 1.51% to $65.86

Thomas Frank 10:42 2025-04-29 UTC+2

US Market News Digest for April 28

The S&P 500 and Nasdaq ended the previous trading session higher, defying choppy performance across Asian and European exchanges. Investors are now focused on the upcoming economic data and earnings

Ekaterina Kiseleva 11:31 2025-04-28 UTC+2

Trump's first 100 days behind us: Markets await tariffs, earnings from giants

Trump policy summaries European stocks rose on Monday after a second straight weekly gain Investors are eyeing tariff changes, as well as a busy week of earnings and economic data

Thomas Frank 11:22 2025-04-28 UTC+2

Wall Street surges: Nasdaq soars 2.74% as tech stocks drive market higher

Procter & Gamble and PepsiCo fell after cutting forecasts, while Hasbro and ServiceNow jumped following their earnings reports. March durable goods orders surged more than expected. Alphabet beat revenue expectations

12:52 2025-04-25 UTC+2

US Market News Digest for April 25

US stock indices closed higher for the third straight session, buoyed by a sharp rally in the technology sector. The Nasdaq surged 2.74%, driven by strong earnings reports from companies

Ekaterina Kiseleva 11:42 2025-04-25 UTC+2

Wall Street on the rise: Nasdaq soars 2.74%, tech leads market higher

Procter & Gamble, PepsiCo fall after forecast cuts Hasbro, ServiceNow jump after results March durable goods jump more than expected Alphabet beats revenue estimates, shares rise after hours Asian markets

Thomas Frank 07:15 2025-04-25 UTC+2
Can't speak right now?
Ask your question in the chat.
Widget callback
 

Dear visitor,

Your IP address shows that you are currently located in the USA. If you are a resident of the United States, you are prohibited from using the services of InstaFintech Group including online trading, online transfers, deposit/withdrawal of funds, etc.

If you think you are seeing this message by mistake and your location is not the US, kindly proceed to the website. Otherwise, you must leave the website in order to comply with government restrictions.

Why does your IP address show your location as the USA?

  • - you are using a VPN provided by a hosting company based in the United States;
  • - your IP does not have proper WHOIS records;
  • - an error occurred in the WHOIS geolocation database.

Please confirm whether you are a US resident or not by clicking the relevant button below. If you choose the wrong option, being a US resident, you will not be able to open an account with InstaForex anyway.

We are sorry for any inconvenience caused by this message.